Data from the clinical trial might give patients a new option for treating migraines.
The alliance will allow MedStar Health to extend its cancer care services and provide symptom management, remote patient monitoring and supportive care.
The G7 continuous glucose monitoring system will have a 15.5-day wear time and last 15% longer than Dexcom G7, according to the company.
A study published in the European Journal of Cancer says inaccurate results and misdiagnoses could occur if diverse populations are not included in clinical research.
The company will use the funds to grow its provider base and expand to Ohio.
The partnership is focused on modernizing the measurement, proof and financial effect of social determinants of health interventions.
In January, Transcarent announced it was acquiring Accolade and taking it private.
The alliance allows Flatiron Health to use Massive Bio's database to match oncology patients to clinical trials within their proximity.
The company will use the funds to grow its 3D technology offerings and expand access to care.
The funding round brings the company's total raise to $1.86 billion since it launched in 2018.
